Publications - Page 3 of 4 | EASAC - Science Advice for the Benefit of Europe

Antimicrobial drug discovery: greater steps ahead

Infectious diseases account for a substantial proportion of deaths worldwide. Continuing progress in the treatment of…

Risks to Plant Health: European Union Priorities for tackling emerging Plant Pests and Diseases

The introduction and spread of pests and diseases among food crops and other plant species in forestry, horticulture and…

Planting the future: opportunities and challenges for using crop genetic improvement technologies for sustainable agriculture

Agriculture faces major challenges to deliver food security at a time of increasing pressures from climate change,…

Direct-to-consumer genetic testing for health-related purposes in the European Union: the view from EASAC and FEAM

Until recently, human genetic testing was mainly confined to specialist medical genetic services, traditionally focusing…

Plant Genetic Resources for Food and Agriculture

Agriculture in Europe faces some major challenges, associated with the need to deliver food security worldwide at a time…

Infectious Diseases and the Future: Policies for Europe

Summaries of the EASAC report: European Public Health and Innovation Policy for Infectious Disease: The View from EASAC …

Impact of Engineered Nanomaterials on Health: Considerations for Benefit-Risk Assessment

Nanotechnology and its importance for Europe Nanotechnology encompasses the design, characterisation, production and…

European Public Health and iInnovation Policy for Infectious Disease: the View from EASAC

There have been major advances during the past century in research into and treatment of infectious disease. However,…

The Lancet

Health benefits of policies to mitigate climate change

Realising European Potential in Synthetic Biology: Scientific Opportunities and Good Governance

Synthetic biology covers the design and construction of novel biological components, systems and processes "that are not…

Climate Change and Infectious Diseases in Europe

Climate exerts both direct and indirect effects on the appearance and spread of human and animal infectious diseases.…

Healthcare-associated Infections: the View from EASAC

Healthcare-associated infections are an increasing problem for the European Union. Many Member States are spending a…

Drug-resistant Tuberculosis

Worldwide, more than nine million people develop active tuberculosis (TB) every year, with 1.7 million dying from the…

Combating the Threat of Zoonotic Infections

Abstract: Most new human pathogens reported in the past 25 years, such as influenza and SARS, have zoonotic origins.…

The use of EU structural funds in science and technology

Abstract: EASAC issued a statement reiterating the role of science and technology in developing the economies of the…

Use of Non-human Primates

Abstract: EASAC believes there is a need for carefully selected research questions to be answered with the use of…

Migration and Infectious Diseases

Abstract: The healthcare screening and treatment processes for migrants entering the EU need to be better evaluated…

Tackling Antibacterial Resistance in Europe

Abstract: Deaths from previously treatable infections will become more common unless there is investment in the…

Vaccines: Innovation and Human Health

Abstract: EASAC published on 9 May 2006 a report on vaccines: innovation and human health. The report focuses on the…

Bureaucracy in the 6th Framework Programme

Abstract: On 22 February 2006 the European Parliament held a workshop to examine the effect that the bureaucracy…

Biosciences Publications